Related Experiment Video
Updated: May 15, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients
Ming-Yuan Hong1, Chin-Chung Tseng, Chia-Chang Chuang
1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
Abstract:
Conventional markers of kidney function that are familiar to clinicians, including the serum creatinine and blood urea nitrogen levels, are unable to reveal genuine injury to the kidney, and their use may delay treatment. Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine, and the predictive role and pathogenic mechanism of MIF deregulation during kidney infections involving acute kidney injury (AKI) are not currently known. In this study, we showed that elevated urinary MIF levels accompanied the development of AKI during kidney infection in patients with acute pyelonephritis (APN). In addition to the MIF level, the urinary levels of interleukin (IL)-1β and kidney injury molecule (KIM)-1 were also upregulated and were positively correlated with the levels of urinary MIF. An elevated urinary MIF level, along with elevated IL-1β and KIM-1 levels, is speculated to be a potential biomarker for the presence of AKI in APN patients.
Insights
Elevated urinary macrophage migration inhibitory factor (MIF) levels indicate acute kidney injury (AKI) in patients with acute pyelonephritis (APN). This finding may lead to earlier diagnosis and treatment of kidney infections.
Area of Science:
- Nephrology
- Immunology
- Biochemistry
Background:
- Conventional kidney function markers like serum creatinine and blood urea nitrogen may not detect acute kidney injury (AKI) early.
- The role of macrophage migration inhibitory factor (MIF) in kidney infections leading to AKI is not well understood.
Purpose of the Study:
- To investigate the potential of urinary MIF as a biomarker for AKI in patients with acute pyelonephritis (APN).
Main Methods:
- Measured urinary levels of MIF, interleukin-1β (IL-1β), and kidney injury molecule-1 (KIM-1) in patients with APN.
- Correlated these levels with the presence and severity of AKI.
Main Results:
- Urinary MIF levels were elevated in patients who developed AKI during APN.
- Urinary IL-1β and KIM-1 levels were also upregulated and positively correlated with urinary MIF.
- Elevated urinary MIF, IL-1β, and KIM-1 suggest potential AKI in APN patients.
Conclusions:
- Urinary MIF, along with IL-1β and KIM-1, may serve as valuable biomarkers for detecting AKI in APN.
- These biomarkers could facilitate earlier diagnosis and intervention for kidney damage in APN.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Urine Studies I: Urinalysis
